Articles by Marylyn Donahue - Pharmaceutical Executive

ADVERTISEMENT

Articles by Marylyn Donahue

Introduction: Getting Your Act Together

Mar 3, 2008

What will it take for pharma to move away from seat-of-your-pants training for product managers?

Everything A Product Manager Needs To Know But Might Not Know To Ask

Mar 3, 2008

A look at what Allergan is doing to take on spotty product manager training

The Birth Of A Product Manager's Training Program

Mar 3, 2008

Product manager training should be customized to meet a company's changing needs. But how do you do it?

The Future is Now: Consultants Spotlight

Nov 3, 2007

DIRE PREDICTIONS ABOUT the pharmaceutical industry have been made before. Indeed, they're made so often it's begun to resemble a chorus in a Greek tragedy: The industry is in trouble, really big trouble. The pipeline is dry, share value performance poor, sales and marketing spending on the rise, legal and regulatory constraints are tightening, and its image...well, think tobacco industry.

Introduction: Turning The Battleship Around

Nov 3, 2007

IMAGINE: YOU ARE THE CEO of a top pharmaceutical company. For years business has been good, very good. You've produced important, blockbuster drugs. Big profits are predicted for the industry in the future ($1.3 trillion by 2020). Only problem is, your current business model is not sustainable. Change, or lose out.

Setting Up Shop on Second Life

An online universe opens up a virtual world of possibilities for businesses, including consultancies, to interact with their clients
Nov 2, 2007

An interview with Claus Nehmzow of PA Consulting Group, on doing business in the virtual world Second Life, where PA has recently opened a new "office."

Turning The Battleship Around

Nov 2, 2007

Top consultants possess one thing in common: the ability to think independently. So Pharmaceutical Executive has turned to more than 20 top consultants to see what they're thinking about the industry today.

When Branding Is Art

Oct 15, 2007

The direct-to-consumer marketing campaign for havidol, a drug for dysphoric social attention consumption deficit anxiety disorder, is drawing lots of public reaction. (but neither the drug nor the disease is real.)

How to Market with Integrity

Oct 15, 2007

Lynn Upshaw posits that marketing with integrity is key to success in these skeptical times. To do so, a company has to live its brand. In his book, Upshaw tells you how.

ADVERTISEMENT

Click here